You are on page 1of 4

LAST CHANCE TO REGISTER

DEADLINE: 1 September 2020

Due to the COVID-19 pandemic, many laboratories were


compelled to upgrade their operations and expand their services
in order to meet the exponential increase in demand for blood
works and other laboratory tests in a concerted and dire effort to
stop the new virus from spreading. Capacities were increased and
organizations had to be immediately trained on the new processes
involved in the diagnosis and treatment of this new virus.

This workshop seeks to assist the healthcare organization in


developing their systems, processes and modes of measuring
performance indicators which can demonstrate compliance to the
specified requirements of the international standards and facilitate
delivery of safe high quality of care. The sessions will give an
introduction to the requirements of the accreditation standards
of ISO 15189 for Laboratory.
International Quality Accreditation Standards for
Laboratory (ISO 15189:2012)
4 September 2020 | 1:00 to 7:00 PM

***5 PMA-CPD Units***

LABORATORY ACCREDITATION is a procedure by which an


authoritative body gives formal recognition of technical competence for
specific tests/measurements, based on third party assessment and
following international standards. The general requirements for
laboratories to be considered competent to carry out medical tests are
specified in the International Standard ISO 15189.

BENEFITS OF ACCREDITATION

Accredited laboratories with international criteria have the following


advantages:

 Increased confidence in Testing/Calibration Reports issued by the


laboratory.
 Better control of laboratory operations due to sound Quality
Assurance System and technically competent staff.
 Potential increase in business due to enhanced customer
confidence and satisfaction.
 Accredited laboratories are publicized by the Accreditation Body by
putting their name on its website.
 Users of accredited laboratories enjoy greater access for their
products, in both domestic and international markets.
 Time and cost-savings due to reduction or elimination of the need
for retesting of products.
ENDORSED BY THE DEPARTMENT OF HEALTH

You might also like